Mustafa Ali, M. K., Zabor, E. C., Abdurakhmanov, K., Zureigat, H., Mohamed, A. N., Alchirazi, M. A., . . . Carraway, H. E. (2026). Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR‐ABL1 transcript decline velocity in chronic myeloid leukemia: A 16‐year real‐world study. Cancer (0008543X), 132(14), 1-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Mustafa Ali, Moaath K., et al. "Longitudinal Analysis of Tyrosine Kinase Inhibitor Therapy Outcomes and BCR‐ABL1 Transcript Decline Velocity in Chronic Myeloid Leukemia: A 16‐year Real‐world Study."
Cancer (0008543X) 132, no. 14 (2026): 1-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Mustafa Ali, Moaath K., et al. "Longitudinal Analysis of Tyrosine Kinase Inhibitor Therapy Outcomes and BCR‐ABL1 Transcript Decline Velocity in Chronic Myeloid Leukemia: A 16‐year Real‐world Study."
Cancer (0008543X), vol. 132, no. 14, 2026, pp. 1-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.